latest update:
[TrialBase DB]

trial summary · NCT06770023

Bridge to Lung Transplant With Trans-septal Extra-corporeal Membrane Oxygenation (ECMO) for Right Heart Failure From Pulmonary Hypertension

A Pilot Study of Transseptal ECMO With the Protek Solo Cannula in Lung Transplant Candidates With Right Heart Failure From Pulmonary Hypertension

Trial record from the TrialBase DB dataset, status RECRUITING, condition Lung Transplant, sponsored by Mayo Clinic. Facts below are exported values from the current release, not inferred or edited prose.

registry NCT06770023phase PHASE1enrollment 4start 2026-12-11

Summary

The brief summary is the registry's published description, capped for length. Field definitions, types, and provenance rules are in the data dictionary.

The purpose of this study is to determine if transseptal extra-corporeal membrane oxygenation (ECMO) can bridge pulmonary hypertension- right heart failure (PH-RVF) patients to lung transplant safely.

Source record: https://clinicaltrials.gov/study/NCT06770023

Facts

registry idNCT06770023
primary registryclinicaltrials-gov
recruitment statusRECRUITING
phasePHASE1
study typeINTERVENTIONAL
lead conditionLung Transplant
sponsorMayo Clinic
sponsor classOTHER
enrollment4
start date2026-12-11
primary completion2027-12
completion2028-12
results postednot reported

Conditions

  • Lung Transplant
  • Pulmonary Hypertension

Interventions

  • Protek Solo Transseptal Cannula

Countries

  • United States

Intervention types: DEVICE

Work with this record